CLVR vs PATH
Clever Leaves Holdings Inc (CLVR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Clever Leaves Holdings Inc (CLVR) is a drug manufacturers - specialty & generic company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CLVR revenue for 2023-12-31 was $17.4M. Net income was -$17.9M. Revenue was up 6.1% from 2022-12-31 to 2023-12-31. CLVR currently screens at market cap $1.4K.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CLVR currently screens at market cap $1.4K. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CLVR and PATH stock pages for the full models.
Not investment advice.